A review of compliance to treatment in Alzheimer's disease: potential benefits of a transdermal patch

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.23, Iss.11, 2007-11, pp. : 2705-2713

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A pilot randomized controlled trial evaluating an integrated treatment of rivastigmine transdermal patch and cognitive stimulation in patients with Alzheimer's disease

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, Vol. 30, Iss. 9, 2015-09 ,pp. : 965-975

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Potential Treatment for Alzheimer's Disease?

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 39, Iss. 12, 1991-12 ,pp. : 1242-1243

John Wiley & Sons Inc

Access to resources Recommend Favorite

The ACTION study: methodology of a trial to evaluate safety and efficacy of a higher dose rivastigmine transdermal patch in severe Alzheimer's disease

By Farlow Martin R. Grossberg George Gauthier Serge Meng Xiangyi Olin Jason T.

Current Medical Research and Opinion, Vol. 26, Iss. 10, 2010-10 ,pp. : 2441-2447

Informa Healthcare

Access to resources Recommend Favorite

Real-life effectiveness and tolerability of the rivastigmine transdermal patch in patients with mild-to-moderate Alzheimer's disease: the EMBRACE study

By Gauthier Serge

Current Medical Research and Opinion, Vol. 29, Iss. 8, 2013-08 ,pp. : 989-1000

Informa Healthcare

Access to resources Recommend Favorite

The Neurosurgical Treatment of Alzheimer's Disease: A Review

Stereotactic and Functional Neurosurgery, Vol. 92, Iss. 5, 2014-09 ,pp. : 269-281

Karger

Access to resources Recommend Favorite